Key Takeaways
- Oracle shares have surrendered their entire 2025 rally during 2026, yet the stock trades at a reasonable 17.2x forward Fiscal 2027 non-GAAP earnings of $8.14.
- Management projects 34% revenue expansion in Fiscal 2027, with total sales expected to surpass $90 billion.
- Elevated interest rates combined with $19.9 billion in fresh equity issuance are constraining EPS expansion to approximately 18.5%.
- Mizuho maintained its Outperform stance with a $320 target, highlighting robust operational execution and expanding cloud infrastructure.
- Analyst consensus stands at Strong Buy with a $251.77 mean target, suggesting approximately 79% potential appreciation.
The 2026 performance of Oracle shares has been disappointing. ORCL has completely reversed its 2025 appreciation, trading near $144.83 as of Tuesday, despite continued expansion in the company’s core operations.
While the share price decline has been notable, the fundamental business metrics paint a compelling picture. Oracle’s management is targeting revenue exceeding $90 billion in Fiscal 2027, marking a substantial 34% increase year-over-year. This growth trajectory would represent the company’s fastest revenue expansion in more than ten years.
Oracle Cloud Infrastructure stands at the center of this expansion narrative. OCI delivered an impressive 120% constant currency growth rate during the most recent quarter. Artificial intelligence applications are fueling this surge in demand, with company leadership indicating accelerated timeline execution for bringing new capacity online in select instances.
The company’s latest Q1 Fiscal 2027 performance exceeded expectations across both top and bottom lines. Non-GAAP earnings per share reached $1.92, representing nearly 30% year-over-year improvement. This achievement extends Oracle’s streak to three consecutive quarters of surpassing revenue and EPS projections, as highlighted by Mizuho.
Mizuho reaffirmed its Outperform stance while maintaining a $320 price objective. The investment firm emphasized Oracle’s operational expense management, noting operating margin expansion of approximately 35 basis points year-over-year even amid gross margin challenges.
Profitability Growth Confronts Significant Obstacles
While topline metrics appear robust, earnings per share dynamics present a more nuanced situation. Oracle executed a $19.9 billion equity offering to finance its growth initiatives. This share dilution, coupled with the higher interest rate environment, constrains non-GAAP EPS growth to roughly 18.5% annually, significantly trailing revenue expansion rates.
Oracle maintains $125.3 billion in outstanding debt obligations, positioning it among the most highly leveraged technology enterprises. Free cash flow registered negative $5.4 billion during Q1 2027, extending a pattern observed throughout the previous fiscal period. Leadership anticipates Fiscal 2027 and 2028 will represent peak capital investment years, with expectations of transitioning toward self-funded operations thereafter.
Following just the initial quarter of Fiscal 2027, guidance received an upward revision, with net capital expenditure projections capped at $70 billion maximum.
Analyst Perspectives
Investment analyst sentiment skews decidedly positive though perspectives vary. UBS elevated its price objective to $250. DA Davidson maintained a Buy recommendation with a $225 target. Bernstein preserved its Outperform designation at $325. Conversely, Freedom Broker reduced its target to $205 while Stifel decreased to $200, both referencing margin compression concerns.
InvestingPro intelligence reveals 14 analysts upgraded earnings projections prior to the forthcoming reporting period. The equity’s PEG ratio registers at 0.51, which InvestingPro identifies as undervalued compared to intrinsic value assessments.
Across Wall Street, ORCL commands a Strong Buy consensus rating, supported by 25 Buy recommendations and four Hold ratings over the trailing three-month period. Zero analysts currently assign a Sell rating.
The consensus Wall Street price target stands at $251.77, indicating approximately 79% appreciation potential from present trading levels.





